Ercole Brusamolino - Concepedia

Author

Ercole Brusamolino

Policlinico San Matteo Fondazione

Also Known As

E Brusamolino, E. Brusamolino, ERCOLE BRUSAMOLINO, Ercole Brusamolino

149

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Policlinico San Matteo Fondazione Istituti di Ricovero e Cura a Carattere Scientifico University of Pavia Sapienza University of Rome Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

About

Ercole Brusamolino is an author at Policlinico San Matteo Fondazione specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	41	2.1K
2	Health Sciences	10	11	309
3	Public Health	1	1	45
4	Cell Biology	1	1	12
5	Cellular Therapies	1	1	12

Ercole Brusamolino

Publications

Citations

H-Index

Page 1

	Year	Citations
A Prognostic Score for Advanced Hodgkin's Disease Dirk Hasenclever, Volker Diehl, Jamés O. Armitage, New England Journal of Medicine	1998	1.7K
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer Gianni Bonadonna, Ercole Brusamolino, Pinuccia Valagussa, New England Journal of Medicine	1976	1.3K
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia Francesco Passamonti, Elisa Rumi, Ester Pungolino, The American Journal of Medicine ThrombopoiesisThrombosisPolycythemia VeraHematological MalignancyPrognostic Evaluation	2004	448
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned Simonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi, New England Journal of Medicine	2011	419
Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial John Raemaekers, Marc André, Massimo Federico, Journal of Clinical Oncology	2014	381
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients Francesco Passamonti, Elisa Rumi, Luca Arcaini, Haematologica	2008	260
[ <sup>18</sup> F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study Maurizio Martelli, Luca Ceriani, Emanuele Zucca, Journal of Clinical Oncology	2014	161
Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. Mario Lazzarino, Ester Orlandi, Marco Paulli, Journal of Clinical Oncology	1993	160
Interim Positron Emission Tomography Response–Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study Pier Luigi Zinzani, Alessandro Broccoli, Daniela Gioia, Journal of Clinical Oncology	2016	146
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT Luca Arcaini, S. Burcheri, Andrea Rossi, Annals of Oncology Lymphoid NeoplasiaHcv InfectionViral HepatitisImmunologyHepatitis	2006	145

Page 1